Req ID: 163167
Company: Nova Scotia Health
Location: Central Zone, Bethune Building - QEII
Department: RSH Pharmacy 1026826-APPROACH 2.0 893997
Type of Employment: Temporary Hourly FT long-assignment (100% FTE) x 1 position(s)
Status: Management/Non Union Position
Posting Closing Date: 27-Aug-23
Nova Scotia Health is the largest provider of health services in Nova Scotia, with some specialized services also offered to clients throughout Atlantic Canada. We\'re on a mission to achieve excellence in health, healing and learning through working together, which is reflected in the hospitals, health centres and community-based programs we operate across the province. Our passionate team of professionals provides a variety of high-quality inpatient and outpatient services including academic, tertiary, and quaternary care, as well as continuing care, primary health care, public health, and mental health and addictions. Join a diverse team of innovators, collaborators and creative thinkers today.
Nova Scotia Health\'s Research, Innovation and Discovery portfolio is transforming health care delivery and improving the health of all Nova Scotians by leading initiatives that deliver high-impact health care solutions and developing strategic partnerships with clinical champions, industry, healthcare foundations, governments and academic partners. By pairing leading researchers, innovators, and clinicians with entrepreneurs through our newly formed Health Innovation, Research and Discovery Hub, their creative solutions are improving health and health care while also contributing directly to Nova Scotia\'s economy.
About the Opportunity
Reporting to the APPROACH 2.0 Nova Scotia Primary Investigator (PI) and the Central Zone Pharmacy Director, the Research Coordinator (Non-Clinical) supports research activities related to the APPROACH 2.0 study and other pharmacy program research related to the therapeutics and prophylactics for emerging and re-emerging infections (i.e., COVID-19, influenza, sexually transmitted and blood-borne infections). The APPROACH 2.0 study explores human immunodeficiency virus (HIV), hepatitis C (HCV), and syphilis testing in community pharmacies. This study is part of the REACH HIV Team grant \xe2\x80\x9cTesting, Reaching the Undiagnosed and Linkages to Care\xe2\x80\x9d funded by CIHR.
Study/Clinical Trial Coordination (50%)
MNCJobz.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.